Search Results

Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole.

• Authors : Yoshioka, Kota¹ (AUTHOR) ; Manne-Goehler, Jennifer² (AUTHOR); Maguire, James H.³ (AUTHOR)

• Source: PLoS Neglected Tropical Diseases. 6/22/2020, Vol. 14 Issue 6, p1-15. 15p.

Record details

Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.

• Authors : Cardoso CS; School of Medicine, Federal University of São João del-Rei, Divinópolis, Brazil.; Ribeiro ALP

Subjects: Chagas Disease/Chagas Disease/Chagas Disease/*drug therapy ; Nitroimidazoles/Nitroimidazoles/Nitroimidazoles/*administration & dosage ; Trypanocidal Agents/Trypanocidal Agents/Trypanocidal Agents/*administration & dosage

• Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Nov 01; Vol. 12 (11), pp. e0006814. Date of Electronic Publication: 2018 Nov 01 (Print Publication: 2018).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection

Record details

Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2011-2018.

• Authors : Herwaldt BL; Dougherty CP; Allen CK

Subjects: Chagas Disease/Chagas Disease/Chagas Disease/*drug therapy ; Drugs, Investigational/Drugs, Investigational/Drugs, Investigational/*therapeutic use ; Nitroimidazoles/Nitroimidazoles/Nitroimidazoles/*therapeutic use

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2018 Jul 27; Vol. 67 (29), pp. 803-805. Date of Electronic Publication: 2018 Jul 27.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic

Record details

Chagas disease 101.

• Authors : Clayton, Julie¹

Subjects: *Chagas' disease; *Trypanosoma cruzi; *Infectious disease transmissionUnited States; Latin America

• Source: Nature. 6/24/2010 Supplement, Vol. 465 Issue 7301, pS4-S5. 2p. 1 Diagram.

Record details

Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents.

• Authors : Gómez-Escobedo R; Departamento de Parasitología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 07738, Mexico.; Méndez-Álvarez D

Subjects: Trypanocidal Agents*/Trypanocidal Agents*/Trypanocidal Agents*/pharmacology ; Trypanocidal Agents*/Trypanocidal Agents*/Trypanocidal Agents*/chemistry ; NADH, NADPH Oxidoreductases*/NADH, NADPH Oxidoreductases*/NADH, NADPH Oxidoreductases*/antagonists & inhibitors

• Source: Molecules (Basel, Switzerland) [Molecules] 2024 Aug 10; Vol. 29 (16). Date of Electronic Publication: 2024 Aug 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2001-2021.

• Authors : Abbott A; Montgomery SP; Chancey RJ

Subjects: Drug-Related Side Effects and Adverse Reactions*; Chagas Disease/Chagas Disease/Chagas Disease/*drug therapy ; Drugs, Investigational/Drugs, Investigational/Drugs, Investigational/*therapeutic use

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Mar 11; Vol. 71 (10), pp. 371-374. Date of Electronic Publication: 2022 Mar 11.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic

Record details

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review.

• Authors : Macklis PC; Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, 2012 Kenny Road, Rm 232, Columbus, OH, 43212, USA.; Dulmage B

Subjects: Skin Diseases/Skin Diseases/Skin Diseases/*chemically induced; Clinical Trials as Topic ; Drug Approval

• Source: Drugs in R&D [Drugs R D] 2020 Sep; Vol. 20 (3), pp. 171-187.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print Cited Medium: Internet ISSN:

Record details